For research use only
| Cat No. | ABC-TC0204 |
| Product Type | Human Lymphoma Cell Lines |
| Cell Type | Lymphoblast |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Burkitt’s Lymphoma |
| Product Code | DAUDI; NK-10A; NK-10a; NK 10a; NK10a; N |
Daudi Burkitt Lymphoma Cells are EBV-positive and used for antigen presentation, lymphocyte transformation, and hematological malignancy modeling.
Daudi is a human-derived Burkitt’s lymphoma cell line originally isolated from the peripheral blood of a 16-year-old male patient with Burkitt’s lymphoma. These cells originate from B lymphocytes in the lymphatic tissue and are malignant, representing an aggressive form of non-Hodgkin’s lymphoma. Daudi cells grow in suspension and can be continuously passaged in vitro. They exhibit a predominantly round morphology, typical of lymphoid cells. Characteristically, Daudi cells express surface markers consistent with B-cell lineage, such as CD19 and CD20, and display high levels of Epstein-Barr virus (EBV) genome integration, which contributes to their oncogenic properties. They also express immunoglobulin heavy and light chains, reflecting their origin from mature B cells. Daudi cells are widely used as a model for studying EBV-associated lymphomas, B-cell biology, and lymphoma therapeutics, given their unique viral and oncogenic features.
| Product Code | DAUDI; NK-10A; NK-10a; NK 10a; NK10a; N |
| Species | Human |
| Cat.No | ABC-TC0204 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphoblast |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Burkitt’s Lymphoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lymphoma Cell Lines |
These well-characterized Daudi B lymphoblasts have been extensively used in the study of leukemogenesis, acting as a reliable in vitro model for understanding the intricacies of B cell biology. Their utility extends to the analysis of B cell surface antigens, supporting studies on antigen expression and characterization. In addition, Daudi cells are employed in the testing of cytotoxic drugs, mutational analysis, and investigations into apoptotic mechanisms, providing valuable insights for research across these pivotal areas in oncology and immunology.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
